Matches in SemOpenAlex for { <https://semopenalex.org/work/W3130107892> ?p ?o ?g. }
- W3130107892 abstract "The association of circulating lipids with clinical outcomes of drug-resistant castration-resistant prostate cancer (DR-CRPC) is not fully understood. While it is known that increases in select lipids correlate to decreased survival, neither the mechanisms mediating these alterations nor the correlation of resistance to drug treatments is well characterized.This gap-in-knowledge was addressed using in vitro models of non-cancerous, hormone-sensitive, CRPC and drug-resistant cell lines combined with quantitative LC-ESI-Orbitrap-MS (LC-ESI-MS/MS) lipidomic analysis and subsequent analysis such as Metaboanalyst and Lipid Pathway Enrichment Analysis (LIPEA).Several lipid regulatory pathways were identified that are associated with Docetaxel resistance in prostate cancer (PCa). These included those controlling glycerophospholipid metabolism, sphingolipid signaling and ferroptosis. In total, 7460 features were identified as being dysregulated between the cell lines studied, and 21 lipid species were significantly altered in drug-resistant cell lines as compared to nonresistant cell lines. Docetaxel resistance cells (PC3-Rx and DU145-DR) had higher levels of phosphatidylcholine (PC), oxidized lipid species, phosphatidylethanolamine (PE), and sphingomyelin (SM) as compared to parent control cells (PC-3 and DU-145). Alterations were also identified in the levels of phosphatidic acid (PA) and diacylglyceride (DAG), whose levels are regulated by Lipin (LPIN), a phosphatidic acid phosphatase that converts PA to DAG. Data derived from cBioPortal demonstrated a population of PCa patients expressing mutations aligning with amplification of LPIN1, LPIN2 and LPIN3 genes. Lipin amplification in these genes correlated to decreased survival in these patients. Lipin-1 mRNA expression also showed a similar trend in PCa patient data. Lipin-1, but not Lipin-2 or - 3, was detected in several prostate cancer cells, and was increased in 22RV1 and PC-3 cell lines. The increased expression of Lipin-1 in these cells correlated with the level of PA.These data identify lipids whose levels may correlate to Docetaxel sensitivity and progression of PCa. The data also suggest a correlation between the expression of Lipin-1 in cells and patients with regards to prostate cancer cell aggressiveness and patient survivability. Ultimately, these data may be useful for identifying markers of lethal and/or metastatic prostate cancer." @default.
- W3130107892 created "2021-03-01" @default.
- W3130107892 creator A5018763992 @default.
- W3130107892 creator A5033980467 @default.
- W3130107892 creator A5044961963 @default.
- W3130107892 creator A5058275124 @default.
- W3130107892 creator A5088891828 @default.
- W3130107892 date "2021-02-17" @default.
- W3130107892 modified "2023-09-27" @default.
- W3130107892 title "Identification of lipidomic profiles associated with drug-resistant prostate cancer cells" @default.
- W3130107892 cites W1501141911 @default.
- W3130107892 cites W1513897103 @default.
- W3130107892 cites W1914088945 @default.
- W3130107892 cites W1935719270 @default.
- W3130107892 cites W1969810164 @default.
- W3130107892 cites W1972917887 @default.
- W3130107892 cites W1977644244 @default.
- W3130107892 cites W1980937621 @default.
- W3130107892 cites W1988117658 @default.
- W3130107892 cites W1989299822 @default.
- W3130107892 cites W1997183854 @default.
- W3130107892 cites W2003372992 @default.
- W3130107892 cites W2003418017 @default.
- W3130107892 cites W2008091140 @default.
- W3130107892 cites W2014058353 @default.
- W3130107892 cites W2015622779 @default.
- W3130107892 cites W2020811083 @default.
- W3130107892 cites W2041844065 @default.
- W3130107892 cites W2059246206 @default.
- W3130107892 cites W2060952451 @default.
- W3130107892 cites W2062279991 @default.
- W3130107892 cites W2064457967 @default.
- W3130107892 cites W2069121538 @default.
- W3130107892 cites W2072977292 @default.
- W3130107892 cites W2074431213 @default.
- W3130107892 cites W2080046774 @default.
- W3130107892 cites W2084284500 @default.
- W3130107892 cites W2099711117 @default.
- W3130107892 cites W2104450983 @default.
- W3130107892 cites W2108488321 @default.
- W3130107892 cites W2110571546 @default.
- W3130107892 cites W2114843025 @default.
- W3130107892 cites W2125872855 @default.
- W3130107892 cites W2127899544 @default.
- W3130107892 cites W2129185045 @default.
- W3130107892 cites W2136934653 @default.
- W3130107892 cites W2146256698 @default.
- W3130107892 cites W2149441684 @default.
- W3130107892 cites W2152311269 @default.
- W3130107892 cites W2160506865 @default.
- W3130107892 cites W2172096113 @default.
- W3130107892 cites W2265836483 @default.
- W3130107892 cites W2324502461 @default.
- W3130107892 cites W2395626624 @default.
- W3130107892 cites W2559536065 @default.
- W3130107892 cites W2593533643 @default.
- W3130107892 cites W2619512829 @default.
- W3130107892 cites W2706387899 @default.
- W3130107892 cites W2734782517 @default.
- W3130107892 cites W2738428060 @default.
- W3130107892 cites W2762087180 @default.
- W3130107892 cites W2794652227 @default.
- W3130107892 cites W2796231776 @default.
- W3130107892 cites W2803664483 @default.
- W3130107892 cites W2890739664 @default.
- W3130107892 cites W2898859822 @default.
- W3130107892 cites W2946657092 @default.
- W3130107892 cites W2950604004 @default.
- W3130107892 cites W2951448458 @default.
- W3130107892 doi "https://doi.org/10.1186/s12944-021-01437-5" @default.
- W3130107892 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7890620" @default.
- W3130107892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33596934" @default.
- W3130107892 hasPublicationYear "2021" @default.
- W3130107892 type Work @default.
- W3130107892 sameAs 3130107892 @default.
- W3130107892 citedByCount "18" @default.
- W3130107892 countsByYear W31301078922021 @default.
- W3130107892 countsByYear W31301078922022 @default.
- W3130107892 countsByYear W31301078922023 @default.
- W3130107892 crossrefType "journal-article" @default.
- W3130107892 hasAuthorship W3130107892A5018763992 @default.
- W3130107892 hasAuthorship W3130107892A5033980467 @default.
- W3130107892 hasAuthorship W3130107892A5044961963 @default.
- W3130107892 hasAuthorship W3130107892A5058275124 @default.
- W3130107892 hasAuthorship W3130107892A5088891828 @default.
- W3130107892 hasBestOaLocation W31301078921 @default.
- W3130107892 hasConcept C121608353 @default.
- W3130107892 hasConcept C2776330855 @default.
- W3130107892 hasConcept C2776438761 @default.
- W3130107892 hasConcept C2776909261 @default.
- W3130107892 hasConcept C2776952329 @default.
- W3130107892 hasConcept C2778163477 @default.
- W3130107892 hasConcept C2778918659 @default.
- W3130107892 hasConcept C2779723316 @default.
- W3130107892 hasConcept C2780192828 @default.
- W3130107892 hasConcept C2781170229 @default.
- W3130107892 hasConcept C2781190966 @default.
- W3130107892 hasConcept C41625074 @default.
- W3130107892 hasConcept C4733338 @default.
- W3130107892 hasConcept C502942594 @default.